Other: normal saline

( DrugBank: - / KEGG DRUG: - )

---

5 diseases

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,898 / 薬物数 : 2,785 - (DrugBank : 360) / 標的遺伝子数 : 265 - 標的パスウェイ数 : 239 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

97. 潰瘍性大腸炎

---

臨床試験数 : 3,566 / 薬物数 : 2,369 - (DrugBank : 339) / 標的遺伝子数 : 210 - 標的パスウェイ数 : 245 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

222. 一次性ネフローゼ症候群

---

臨床試験数 : 576 / 薬物数 : 519 - (DrugBank : 130) / 標的遺伝子数 : 108 - 標的パスウェイ数 : 219 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

226. 間質性膀胱炎（ハンナ型）

---

臨床試験数 : 177 / 薬物数 : 208 - (DrugBank : 60) / 標的遺伝子数 : 87 - 標的パスウェイ数 : 148 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

280. 巨大動静脈奇形（頚部顔面又は四肢病変）

---

臨床試験数 : 36 / 薬物数 : 41 - (DrugBank : 17) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 169 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries